Ryan Specialty Holdings (RYAN) Cash & Equivalents (2020 - 2026)

Ryan Specialty Holdings (RYAN) has 7 years of Cash & Equivalents data on file, last reported at $154.6 million in Q1 2026.

• On a quarterly basis, Cash & Equivalents fell 24.02% year-over-year to $154.6 million in Q1 2026; TTM through Mar 2026 was $154.6 million, a 24.02% decrease from a year earlier, with the FY2025 full-year figure at $158.3 million, down 70.69% from the prior year.
• Cash & Equivalents for Q1 2026 stood at $154.6 million, down from $158.3 million in the prior quarter.
• Over the last five years, Cash & Equivalents for RYAN reached as high as $2.0 billion in Q2 2023 and fell as low as $153.5 million in Q3 2025.
• Historically, Cash & Equivalents has averaged $946.1 million across 5 years, with a median of $838.8 million in 2023.
• Across the five-year window, Cash & Equivalents soared 103.17% in 2022 and plunged 87.45% in 2025, its largest moves.
• Year by year, Cash & Equivalents stood at $1.8 billion in 2022, then tumbled by 52.54% to $838.8 million in 2023, then sank by 35.6% to $540.2 million in 2024, then slumped by 70.69% to $158.3 million in 2025, then dropped by 2.32% to $154.6 million in 2026.
• Per Business Quant data, the three most recent Cash & Equivalents figures were $154.6 million in Q1 2026, $158.3 million in Q4 2025, and $153.5 million in Q3 2025.